Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy

Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy

US Patent 10221455 · Granted Mar 5, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

DCN-1 modulating compounds and methods of use thereof2025
Modulators of DCN-1 and methods of use thereof2025
Methods of using a bispecific antigen-binding construct targeting HER2 for the t2025
Methods of reducing immunogenicity against factor VIII in individuals undergoing2025
Methods of reducing immunogenicity against factor VIII in individuals undergoing2025
Methods of reducing immunogenicity against factor VIII in individuals undergoing2025
Methods of reducing immunogenicity against factor VIII in individuals undergoing2025
Methods of reducing immunogenicity against factor VIII in individuals undergoing2025
Nucleic acid molecules and uses thereof for non-viral gene therapy2025
Optimized factor IX gene2025
Factor VIII chimeric and hybrid polypeptides, and methods of use thereof2025
Factor VIII chimeric and hybrid polypeptides, and methods of use thereof2025